May 27, 2020
InMed Releases CBN Preclinical Results in Glaucoma
May 12, 2020
InMed Files PCT Patent Application for Neuroprotection in Glaucoma
Mar 10, 2020
Sight Sciences Announces Publication of First-Ever Multicenter MIGS study in Childhood Glaucoma
Mar 05, 2020
Allergan Receives FDA Approval for DURYSTA(TM) (bimatoprost implant) the First and Only Intracameral Biodegradable Sustained-Release Implant to lower Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension Patients
Feb 25, 2020
Allergan to Present New Data for Investigational Bimatoprost Sustained-Release at American Glaucoma Society Annual Meeting
Jan 27, 2020
Potent affronEYE® Saffron Extract May Lower Risk of Glaucoma
Dec 31, 2019
2019 Ocular Hypertension Pipeline Review
Dec 05, 2019
Unique Tonometer, Diaton, Helps to Meet and Exceed Joint Commission Guideline for Disinfection and Sterilization
Oct 22, 2019
International MIGS Study Confirms Long-Term Safety and Efficacy of the OMNI® Surgical System Predicate Device (VISCO360®)
Oct 10, 2019
Ivantis Completes Enrollment of International SPECTRUM Registry for Hydrus Microstent
Oct 10, 2019
Myra Medical, A Shifamed Portfolio Company, Closes $3M In Seed Financing
Oct 09, 2019
Injectsense Demonstrates Animal-to-Cloud IOP Sensing Pathway for Glaucoma
May 03, 2019
Allergan to Present Two Podium Presentations on Bimatoprost Sustained-Release (SR) at The American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Apr 23, 2019
Ivantis Announces Publication of Landmark Comparative MIGS Clinical Trial Results in Leading Ophthalmic Journal
Mar 14, 2019
Ivantis Announces 24-Month Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial
Mar 14, 2019
Clinical Study Demonstrates Long Term IOP Reduction with the OMNI® Surgical System Predicate Device (TRAB®360) in Micro-Invasive Glaucoma Surgery
Oct 22, 2018
Santen Announces Initiation of Phase 3 Clinical Development Program (SPECTRUM) in the United States Evaluating Omidenepag Isopropyl (DE-117) for the Treatment of Glaucoma or Ocular Hypertension
Aug 13, 2018
Ivantis Announces FDA Approval for Its Innovative Hydrus® Microstent Device for Minimally Invasive Glaucoma Surgery (MIGS)
May 16, 2018
iSTAR Medical's MINIject delivers exceptional 6-month results in first-in-human trial
Apr 12, 2018
New Data from the HORIZON Trial of the Hydrus® Microstent Shows Significantly Lower IOP and Medication Use at 24 Months in a US Patient Cohort